Attributes | Values |
---|
rdf:type
| |
Description
| - 41 patients with psoriasis were treated with 7,5 mg or 15 mg MTX administered once a week. The pharmacokinetic of MTX were evaluated at week 1 and 13, MTX in erythrocytes and the PASI-score were evaluated repeatedly. There was a strong correlation between MTX AUC at week 1 and PASI at week 13 (rho = -0,08, p 0,0001).
- 41 patients with psoriasis were treated with 7,5 mg or 15 mg MTX administered once a week. The pharmacokinetic of MTX were evaluated at week 1 and 13, MTX in erythrocytes and the PASI-score were evaluated repeatedly. There was a strong correlation between MTX AUC at week 1 and PASI at week 13 (rho = -0,08, p 0,0001). (en)
- Nemocní s těžkou psoriázou (N = 41) byly léčeni MTX v nízkých dávkách (7,5 nebo 15 mg) 1x týdně. Farmakokinetika MTX, jeho koncentrace v erytrocytech a klinický stav (skore PASI) byly hodnoceny opakovaně v průběhu prvních 13ti týdnů. Byla nalezena vysoce signifikantní korelace mezi AUCMTX v prvním týdnu a stavem onemocnění kůže ve třináctém týdnu (PASI) (rho = -0,08, p 0,0001) (cs)
|
Title
| - Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis
- Farmakokinetika a farmakodynamika nízkých dávek metotrexátu v léčbě těžké psoriázy (cs)
- Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis (en)
|
skos:prefLabel
| - Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis
- Farmakokinetika a farmakodynamika nízkých dávek metotrexátu v léčbě těžké psoriázy (cs)
- Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis (en)
|
skos:notation
| - RIV/00216208:11150/05:00003501!RIV06-MSM-11150___
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11150/05:00003501
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - methotrexate; psoriasis; pharmacokinetics (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Basic and Clinical Pharmacology and Toxicology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Chládek, Jaroslav
- Vaněčková, Jaroslava
- Grim, Jiří
- Martínková, Jiřina
- Šimková, Marie
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |